To determine whether activation of mTORC1 signaling was associated with angiogenesis in rosacea, we first detected the activity of mTORC1 in endothelial cells in the lesional skin of rosacea patients and mouse model via co-immunostaining of pS6 and CD31. Here, PECAM1 is linked to rosacea.